Glessner Coleen, EVP of Quality and Ethics and CPL at Emergent BioSolutions Inc. ($EBS), sold shares on the open market once in the last 365 days for a total of $306,000. Her most recent sale occurred on October 7, 2025. These sales rank 7,501st among 11,678 individual insiders, below the average sale amount of $8.6 million across 6 transactions. She made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 3, 2026 | Emergent BioSolutions Inc. | $EBS | Glessner Coleen | EVP, Quality & Ethics, and CPL | A | Employee Stock Option (Right to buy) | 44834 | $0.00 | 294,447.0000 | 56,700,000 | 17.96% | 0.08% |
| March 5, 2026 | Emergent BioSolutions Inc. | $EBS | Glessner Coleen | EVP, Quality & Ethics, and CPL | F | Common Stock | 8199 | $8.44 | 104,108.0000 | 56,700,000 | 7.30% | 0.01% |
| March 1, 2026 | Emergent BioSolutions Inc. | $EBS | Glessner Coleen | EVP, Quality & Ethics, and CPL | F | Common Stock | 313 | $8.15 | 112,307.0000 | 56,700,000 | 0.28% | 0.00% |
| Feb. 6, 2026 | Emergent BioSolutions Inc. | $EBS | Glessner Coleen | EVP, Quality & Ethics, and CPL | F | Common Stock | 2852 | $10.92 | 112,620.0000 | 56,700,000 | 2.47% | 0.01% |
| Feb. 6, 2026 | Emergent BioSolutions Inc. | $EBS | Glessner Coleen | EVP, Quality & Ethics, and CPL | D | Common Stock | 28847 | $10.92 | 115,472.0000 | 56,700,000 | 19.99% | 0.05% |
| Oct. 7, 2025 | Emergent BioSolutions Inc. | $EBS | Glessner Coleen | EVP, Quality & Ethics, and CPL | S | Common Stock | 30608 | $10.00 | 144,319.0000 | 56,700,000 | 17.50% | 0.05% |
| June 8, 2025 | Emergent BioSolutions Inc. | $EBS | Glessner Coleen | EVP, Quality & Ethics, and CPL | F | Common Stock | 1249 | $6.63 | 174,927.0000 | 53,000,000 | 0.71% | 0.00% |
| April 7, 2025 | Emergent BioSolutions Inc. | $EBS | Glessner Coleen | EVP, Quality & Ethics, and CPL | F | Common Stock | 480 | $4.44 | 176,176.0000 | 53,000,000 | 0.27% | 0.00% |
| March 6, 2025 | Emergent BioSolutions Inc. | $EBS | Glessner Coleen | EVP, Quality & Ethics, and CPL | A | Employee Stock Options (Right to Buy) | 62500 | $0.00 | 249,613.0000 | 53,000,000 | 33.40% | 0.12% |
| March 6, 2025 | Emergent BioSolutions Inc. | $EBS | Glessner Coleen | EVP, Quality & Ethics, and CPL | A | Common Stock | 62500 | $0.00 | 176,656.0000 | 53,000,000 | 54.75% | 0.12% |
| March 1, 2025 | Emergent BioSolutions Inc. | $EBS | Glessner Coleen | EVP, Quality & Ethics, and CPL | F | Common Stock | 313 | $7.48 | 114,156.0000 | 53,000,000 | 0.27% | 0.00% |
| Feb. 12, 2025 | Emergent BioSolutions Inc. | $EBS | Glessner Coleen | EVP, Quality & Ethics, and CPL | D | Common Stock | 24078 | $0.00 | 114,469.0000 | 53,000,000 | 17.38% | 0.05% |
| Feb. 12, 2025 | Emergent BioSolutions Inc. | $EBS | Glessner Coleen | EVP, Quality & Ethics, and CPL | D | Common Stock | 5913 | $0.00 | 138,547.0000 | 53,000,000 | 4.09% | 0.01% |
| Dec. 8, 2024 | Emergent BioSolutions Inc. | $EBS | Glessner Coleen | EVP, Quality & Ethics, and CPL | F | Common Stock | 18674 | $9.01 | 144,460.0000 | 55,600,000 | 11.45% | 0.03% |
| June 8, 2024 | Emergent BioSolutions Inc. | $EBS | Glessner Coleen | EVP, Quality & Ethics, and CPL | F | Common Stock | 1249 | $6.19 | 163,134.0000 | 51,200,000 | 0.76% | 0.00% |
| April 7, 2024 | Emergent BioSolutions Inc. | $EBS | Glessner Coleen | EVP, Quality & Ethics, and CPL | F | Common Stock | 585 | $2.29 | 164,383.0000 | 51,200,000 | 0.35% | 0.00% |
| March 13, 2024 | Emergent BioSolutions Inc. | $EBS | Glessner Coleen | EVP, Quality & Ethics, and CPL | A | Employee Stock Options (Right to Buy) | 125000 | $0.00 | 187,113.0000 | 51,200,000 | 201.25% | 0.24% |
| March 1, 2024 | Emergent BioSolutions Inc. | $EBS | Glessner Coleen | EVP, Quality & Ethics, and CPL | F | Common Stock | 381 | $3.39 | 164,968.0000 | 51,200,000 | 0.23% | 0.00% |